{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T11:22:49Z","timestamp":1772191369843,"version":"3.50.1"},"reference-count":39,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T00:00:00Z","timestamp":1637366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>von Willebrand disease (VWD) is reportedly the most common inherited bleeding disorder. This disorder develops as a result of defects and\/or deficiency of the plasma protein von Willebrand factor (VWF). Laboratory testing for VWF-related disorders requires the assessment of both VWF level and VWF activity, the latter requiring multiple assays. As an additional step, an evaluation of VWF structural features by multimer analysis is useful in selective investigations. Multimer analysis is also important for the selection of a suitable VWF therapy preparation (desmopressin, VWF\/FVIII concentrate, recombinant VWF) and the determination of the correct dose for the patient. Based on clinical and laboratory findings, including the analysis of VWF multimers, we classified our patients into individual types of VWD. Our study group included 58 patients. The study group consisted of 66% (38 patients) with VWD type 1, 5% (3 patients) with VWD type 2, 7% (4 patients) with VWD type 3, 5% (3 patients) with mixed type 1\/2A VWD, and 17% (10 patients) comprising an unclassified group. In this article, we provide an overview of our practical experience using a new complementary method\u2014the analysis of von Willebrand factor multimers with a semi-automatic analyzer Hydrasys 2 scan. We explain the principle, procedure, advantages, and pitfalls associated with the introduction of the VWF multimer analysis methodology into standard VWD diagnostics.<\/jats:p>","DOI":"10.3390\/diagnostics11112153","type":"journal-article","created":{"date-parts":[[2021,11,21]],"date-time":"2021-11-21T20:58:21Z","timestamp":1637528301000},"page":"2153","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Multimer Analysis of Von Willebrand Factor in Von Willebrand Disease with a Hydrasys Semi-Automatic Analyzer\u2014Single-Center Experience"],"prefix":"10.3390","volume":"11","author":[{"given":"Ingrid","family":"Skornova","sequence":"first","affiliation":[{"name":"National Center of Hemostasis and Thrombosis, Department of Hematology and Transfusiology, Comenius University in Bratislava, Jessenius Faculty of Medicine in Martin and University Hospital in Martin, 03601 Martin, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Simurda","sequence":"additional","affiliation":[{"name":"National Center of Hemostasis and Thrombosis, Department of Hematology and Transfusiology, Comenius University in Bratislava, Jessenius Faculty of Medicine in Martin and University Hospital in Martin, 03601 Martin, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3305-0269","authenticated-orcid":false,"given":"Jan","family":"Stasko","sequence":"additional","affiliation":[{"name":"National Center of Hemostasis and Thrombosis, Department of Hematology and Transfusiology, Comenius University in Bratislava, Jessenius Faculty of Medicine in Martin and University Hospital in Martin, 03601 Martin, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Zolkova","sequence":"additional","affiliation":[{"name":"National Center of Hemostasis and Thrombosis, Department of Hematology and Transfusiology, Comenius University in Bratislava, Jessenius Faculty of Medicine in Martin and University Hospital in Martin, 03601 Martin, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juraj","family":"Sokol","sequence":"additional","affiliation":[{"name":"National Center of Hemostasis and Thrombosis, Department of Hematology and Transfusiology, Comenius University in Bratislava, Jessenius Faculty of Medicine in Martin and University Hospital in Martin, 03601 Martin, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavol","family":"Holly","sequence":"additional","affiliation":[{"name":"National Center of Hemostasis and Thrombosis, Department of Hematology and Transfusiology, Comenius University in Bratislava, Jessenius Faculty of Medicine in Martin and University Hospital in Martin, 03601 Martin, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miroslava","family":"Dobrotova","sequence":"additional","affiliation":[{"name":"National Center of Hemostasis and Thrombosis, Department of Hematology and Transfusiology, Comenius University in Bratislava, Jessenius Faculty of Medicine in Martin and University Hospital in Martin, 03601 Martin, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Plamenova","sequence":"additional","affiliation":[{"name":"National Center of Hemostasis and Thrombosis, Department of Hematology and Transfusiology, Comenius University in Bratislava, Jessenius Faculty of Medicine in Martin and University Hospital in Martin, 03601 Martin, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Hudecek","sequence":"additional","affiliation":[{"name":"National Center of Hemostasis and Thrombosis, Department of Hematology and Transfusiology, Comenius University in Bratislava, Jessenius Faculty of Medicine in Martin and University Hospital in Martin, 03601 Martin, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Brunclikova","sequence":"additional","affiliation":[{"name":"National Center of Hemostasis and Thrombosis, Department of Hematology and Transfusiology, Comenius University in Bratislava, Jessenius Faculty of Medicine in Martin and University Hospital in Martin, 03601 Martin, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alena","family":"Stryckova","sequence":"additional","affiliation":[{"name":"National Center of Hemostasis and Thrombosis, Department of Hematology and Transfusiology, Comenius University in Bratislava, Jessenius Faculty of Medicine in Martin and University Hospital in Martin, 03601 Martin, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Kubisz","sequence":"additional","affiliation":[{"name":"National Center of Hemostasis and Thrombosis, Department of Hematology and Transfusiology, Comenius University in Bratislava, Jessenius Faculty of Medicine in Martin and University Hospital in Martin, 03601 Martin, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-0035-1569070","article-title":"Treatment of von Willebrand disease","volume":"42","author":"Curnow","year":"2016","journal-title":"Semin. Thromb. Hemost"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1055\/s-0037-1603362","article-title":"Successful Use of a Highly Purified Plasma von Willebrand Factor Concentrate Containing Little FVIII for the Long-Term Prophylaxis of Severe (Type 3) von Willebrand\u2019s Disease","volume":"43","author":"Simurda","year":"2017","journal-title":"Semin. Thromb. Hemost"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1053\/beha.2001.0135","article-title":"Appropriate laboratory assessment as a critical facet in the proper diagnosis and classification of von Willebrand disorder","volume":"14","author":"Favaloro","year":"2001","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1055\/s-0031-1281028","article-title":"Von Willebrand disease: Local diagnosis and management of aglobally distributed bleeding disorder","volume":"37","author":"Favaloro","year":"2011","journal-title":"Semin. Thromb. Hemost"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.5482\/HAMO-13-08-0045","article-title":"Interactions of von Willebrand factor and ADAMTS13 in von Willebrand disease and thrombotic thrombocytopenic purpura","volume":"34","author":"Schneppenheim","year":"2014","journal-title":"H\u00e4mostaseologie"},{"key":"ref_6","unstructured":"\u0160kor\u0148ov\u00e1, I., Slav\u00edk, L., Sta\u0161ko, J., Kubisz, P., Kr\u010dov\u00e1, V., B\u00e1rtov\u00e1, L., Brad\u00e1\u010dov\u00e1, P., Macichov\u00e1, M., \u00dalehlov\u00e1, J., and V\u00e1\u017eanov\u00e1, A. (2020). Hemost\u00e1za; Laborat\u00f3rne Met\u00f3dy, ich Vyu\u017eitie a Interpret\u00e1cia vo Vybran\u00fdch Klinick\u00fdch Situ\u00e1ciach, Laboratorn\u00ed Metody, Jejich Vyu\u017eit\u00ed a Interpretace ve Vybran\u00fdch Klinick\u00fdch Situac\u00edch. Vydalo: P+M, s. r. o."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-0033-1363155","article-title":"Von Willebrand Factor: Form for Function","volume":"40","author":"Yee","year":"2013","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_8","unstructured":"Colman, R.W. (2006). Structure and function of von Willebrand factor. Hemostasis and Thrombosis: Basic Principles and Clinical Practice, Lippincott Williams&Wilkins. [5th ed.]."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Federici, A.B. (2011). Von Willebrand Factor Structure and Function. Von Willebrand Disease, Wiley-Blackwell. [1st ed.].","DOI":"10.1002\/9781444329926"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/jth.12225","article-title":"The secretion of von Willebrand factor from endothelial cells; an increasingly complicated story","volume":"11","author":"Nightingale","year":"2013","journal-title":"J. Thromb. Haemost."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1182\/blood-2013-07-517086","article-title":"Solution structure of the major factor VIII binding region on von Willebrand factor","volume":"123","author":"Shiltagh","year":"2014","journal-title":"Blood"},{"key":"ref_12","first-page":"262","article-title":"Towards personalised therapy for von Willebrand disease: A future role for recombinant products","volume":"14","author":"Favaloro","year":"2016","journal-title":"Blood Transfus."},{"key":"ref_13","first-page":"494","article-title":"Performances of the Hydragel 5 von Willebrand multimers- a new within-day von Willebrand factor (VWF) multimer screening method Evaluation of a new commercial method for von Willebrand factor multimeric analysis","volume":"1","author":"Bowyer","year":"2017","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/ijlh.13107","article-title":"Semi-automated von Willebrand factor multimer assay for von Willebrand disease: Further validation, benefits and limitations","volume":"41","author":"Oliver","year":"2019","journal-title":"Int. J. Lab. Hematol."},{"key":"ref_15","first-page":"717","article-title":"Clinical evaluation of the sebia hydragel von Willebrand factor assay in comparison to electrophoresis and blotting based multimer analysis","volume":"1","author":"Seidel","year":"2017","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_16","first-page":"113","article-title":"Interest of the new rapid test\u201c Hydragel 5 von willebrand multimers\u201d for the analysis of von willebrand multimers","volume":"38","author":"Vasse","year":"2016","journal-title":"Int. J. Lab Hem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e22416","DOI":"10.1002\/jcla.22416","article-title":"Preclinical evaluation of a semi-automated and rapid commercial electrophoresis assay for von Willebrand factor multimers","volume":"32","author":"Pikta","year":"2018","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/rth2.12408","article-title":"Improving diagnosis of von Willebrand disease: Reference ranges for von Willebrand factor multimer distribution","volume":"4","author":"Vangenechten","year":"2020","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e542","DOI":"10.1097\/HS9.0000000000000542","article-title":"Von Willebrand Factor Multimer Densitometric Analysis: Validation of the Clinical Accuracy and Clinical Implications in Von Willebrand Disease","volume":"5","author":"Boender","year":"2021","journal-title":"HemaSphere"},{"key":"ref_20","first-page":"721","article-title":"Sebia Hydragel 5 von Willebrand multimers\u2014A new and rapid von Willebrand factor (VWF) multimer screening method to aid subtyping of type 2 von Willebrand disease (VWD)","volume":"55","author":"Goodfellow","year":"2017","journal-title":"Clin. Chem. Lab Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/rth2.12141","article-title":"Evaluation of a semi-automated von Willebrand factor multimer assay, the Hydragel 5 von Willebrand multimer, by two European Centers","volume":"2","author":"Bowyer","year":"2018","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_22","first-page":"706","article-title":"Clinical evaluation of the Hydragel 5 von Willebrand multimers of Sebia","volume":"55","author":"Lemaitre","year":"2017","journal-title":"Clin. Chem. Lab Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/ijlh.12869","article-title":"Evaluation of a new commercial method for von Willebrand factor multimeric analysis","volume":"40","author":"Crist","year":"2018","journal-title":"Int. J. Lab. Hematol."},{"key":"ref_24","first-page":"484","article-title":"Genetic Background of von Willebrand Disease: History, Current State, and Future Perspectives","volume":"46","author":"Zolkova","year":"2019","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Pikta, M., Vasse, M., Lejniece, S., Smock, K.J., Moser, K.A., Bautista, H., Nouadje, G., and Banys, V. (2021, November 20). Establishing Reference Intervals for von Willebrand Factor Multimers. Available online: https:\/\/abstracts.isth.org\/abstract\/establishing-reference-intervals-for-von-willebrand-factor-multimers\/.","DOI":"10.5937\/jomb0-31941"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.21037\/aob.2018.01.03","article-title":"Diagnosis and management of von Willebrand disease in Slovakia","volume":"3","author":"Kubisz","year":"2018","journal-title":"Ann. Blood"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"345","DOI":"10.21037\/atm.2018.09.10","article-title":"Rare forms of von Willebrand disease","volume":"6","author":"Favaloro","year":"2018","journal-title":"Ann. Transl. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1515\/cclm-2014-0564","article-title":"ABO blood group and von Willebrand factor: Biological implications","volume":"52","author":"Franchini","year":"2014","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1182\/asheducation-2009.1.106","article-title":"Low von Willebrand factor: Sometimes a risk factor and sometimes a disease","volume":"2009","author":"Sadler","year":"2009","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","article-title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease","volume":"5","author":"James","year":"2021","journal-title":"Blood Adv."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/bjh.13064","article-title":"The diagnosis and management of von Willebrand disease: A United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology","volume":"167","author":"Laffan","year":"2014","journal-title":"Br. J. Haematol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): Evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.21037\/aob.2018.03.05","article-title":"Diagnosis and management of von Willebrand disease in Australia","volume":"3","author":"Favaloro","year":"2018","journal-title":"Ann. Blood"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.21037\/aob.2017.12.08","article-title":"Diagnosis and management of von willebrand disease in Spain","volume":"3","author":"Batlle","year":"2018","journal-title":"Ann. Blood"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.21037\/aob.2017.12.05","article-title":"Von Willebrand disease in the United States: Perspective from the Zimmerman program","volume":"3","author":"Flood","year":"2018","journal-title":"Ann. Blood"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"679","DOI":"10.4065\/81.5.679","article-title":"A Practical Approach to Genetic Testing for von Willebrand Disease","volume":"81","author":"Pruthi","year":"2006","journal-title":"Mayo Clin. Proc."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/01.mbc.0000167656.77520.bb","article-title":"The evolving classification of von Willebrand disease","volume":"16","author":"Schneppenheim","year":"2005","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Casonato, A., Daidone, V., Galletta, E., and Bertomoro, A. (2017). Type 2B von Willebrand disease with or without large multimers: A distinction of the two sides of the disorder is long overdue. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0179566"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1182\/blood.V95.6.2000","article-title":"Two novel type 2N von Willebrand disease\u2014Causing mutations that result in defective factor VIII binding, multimerization, and secretion of von Willebrand factor","volume":"95","author":"Allen","year":"2000","journal-title":"Blood"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/11\/11\/2153\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:33:27Z","timestamp":1760168007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/11\/11\/2153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,20]]},"references-count":39,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["diagnostics11112153"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics11112153","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,20]]}}}